Cargando…
Oestrogen receptors β1 and βcx have divergent roles in breast cancer survival and lymph node metastasis
BACKGROUND: The expression of oestrogen receptor (ER) α characterises a subset of breast cancers associated with good response to endocrine therapy. However, the clinical significance of the second ER, ERβ1, and its splice variant ERβcx is still unclear. METHODS: We here report an assessment of ERα,...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150283/ https://www.ncbi.nlm.nih.gov/pubmed/25025959 http://dx.doi.org/10.1038/bjc.2014.398 |
_version_ | 1782332875625988096 |
---|---|
author | Rosin, G de Boniface, J Karthik, G M Frisell, J Bergh, J Hartman, J |
author_facet | Rosin, G de Boniface, J Karthik, G M Frisell, J Bergh, J Hartman, J |
author_sort | Rosin, G |
collection | PubMed |
description | BACKGROUND: The expression of oestrogen receptor (ER) α characterises a subset of breast cancers associated with good response to endocrine therapy. However, the clinical significance of the second ER, ERβ1, and its splice variant ERβcx is still unclear. METHODS: We here report an assessment of ERα, ERβ1 and ERβcx by immunohistochemistry using quantitative digital image analysis of 340 primary tumours and corresponding sentinel lymph nodes. RESULTS: No differences were seen in ER levels in primary tumours vs lymph node metastases. ERβ1 and ERβcx were equally distributed among age groups and tumour histological grades. Loss of ERβ1 in the primary tumour was strongly associated with poor survival. Its prognostic impact was particularly evident in young patients and in high-grade tumours. The worst outcome was seen in the tumours lacking both ERα and ERβ1. ERβcx expression in the primary tumour correlated with a higher risk of lymph node metastasis, and with poor survival when expressed in sentinel node lymphocytes. CONCLUSIONS: Our study reveals highly significant although antagonising roles of ERβ1 and ERβcx in breast cancer. Consequently, we suggest that the histopathological assessment of ERβ1 is of value as a prognostic and potentially predictive biomarker. |
format | Online Article Text |
id | pubmed-4150283 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-41502832015-08-26 Oestrogen receptors β1 and βcx have divergent roles in breast cancer survival and lymph node metastasis Rosin, G de Boniface, J Karthik, G M Frisell, J Bergh, J Hartman, J Br J Cancer Molecular Diagnostics BACKGROUND: The expression of oestrogen receptor (ER) α characterises a subset of breast cancers associated with good response to endocrine therapy. However, the clinical significance of the second ER, ERβ1, and its splice variant ERβcx is still unclear. METHODS: We here report an assessment of ERα, ERβ1 and ERβcx by immunohistochemistry using quantitative digital image analysis of 340 primary tumours and corresponding sentinel lymph nodes. RESULTS: No differences were seen in ER levels in primary tumours vs lymph node metastases. ERβ1 and ERβcx were equally distributed among age groups and tumour histological grades. Loss of ERβ1 in the primary tumour was strongly associated with poor survival. Its prognostic impact was particularly evident in young patients and in high-grade tumours. The worst outcome was seen in the tumours lacking both ERα and ERβ1. ERβcx expression in the primary tumour correlated with a higher risk of lymph node metastasis, and with poor survival when expressed in sentinel node lymphocytes. CONCLUSIONS: Our study reveals highly significant although antagonising roles of ERβ1 and ERβcx in breast cancer. Consequently, we suggest that the histopathological assessment of ERβ1 is of value as a prognostic and potentially predictive biomarker. Nature Publishing Group 2014-08-26 2014-07-15 /pmc/articles/PMC4150283/ /pubmed/25025959 http://dx.doi.org/10.1038/bjc.2014.398 Text en Copyright © 2014 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/3.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ |
spellingShingle | Molecular Diagnostics Rosin, G de Boniface, J Karthik, G M Frisell, J Bergh, J Hartman, J Oestrogen receptors β1 and βcx have divergent roles in breast cancer survival and lymph node metastasis |
title | Oestrogen receptors β1 and βcx have divergent roles in breast cancer survival and lymph node metastasis |
title_full | Oestrogen receptors β1 and βcx have divergent roles in breast cancer survival and lymph node metastasis |
title_fullStr | Oestrogen receptors β1 and βcx have divergent roles in breast cancer survival and lymph node metastasis |
title_full_unstemmed | Oestrogen receptors β1 and βcx have divergent roles in breast cancer survival and lymph node metastasis |
title_short | Oestrogen receptors β1 and βcx have divergent roles in breast cancer survival and lymph node metastasis |
title_sort | oestrogen receptors β1 and βcx have divergent roles in breast cancer survival and lymph node metastasis |
topic | Molecular Diagnostics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150283/ https://www.ncbi.nlm.nih.gov/pubmed/25025959 http://dx.doi.org/10.1038/bjc.2014.398 |
work_keys_str_mv | AT rosing oestrogenreceptorsb1andbcxhavedivergentrolesinbreastcancersurvivalandlymphnodemetastasis AT debonifacej oestrogenreceptorsb1andbcxhavedivergentrolesinbreastcancersurvivalandlymphnodemetastasis AT karthikgm oestrogenreceptorsb1andbcxhavedivergentrolesinbreastcancersurvivalandlymphnodemetastasis AT frisellj oestrogenreceptorsb1andbcxhavedivergentrolesinbreastcancersurvivalandlymphnodemetastasis AT berghj oestrogenreceptorsb1andbcxhavedivergentrolesinbreastcancersurvivalandlymphnodemetastasis AT hartmanj oestrogenreceptorsb1andbcxhavedivergentrolesinbreastcancersurvivalandlymphnodemetastasis |